8-K: Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8th

Supernus Pharmaceuticals will release its first quarter 2024 financial results after market close on May 8, 2024, followed by a conference call.

Summary

• Supernus Pharmaceuticals, a biopharmaceutical company focused on central nervous system (CNS) treatments, will announce its first quarter 2024 financial results on May 8, 2024.
• The company will host a conference call and webcast on the same day at 4:30 p.m. ET to discuss the results.
• The call will include prepared remarks from management, a discussion of business results, and a question-and-answer session.
• A live webcast will be available on the company's investor relations website, and a replay will be available for 60 days.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an upcoming earnings release, which is generally neutral to positive. The company is providing clear communication to investors.

Positives

• The company is providing a clear timeline for the release of its first quarter 2024 results.
• A conference call and webcast will allow investors to engage with management and ask questions.
• The availability of a webcast replay for 60 days ensures accessibility for all interested parties.

Future Outlook

The company will be discussing its first quarter 2024 business and financial results on the conference call.

Management Comments

• Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host the conference call.

Industry Context

This announcement is a standard practice for publicly traded companies to inform investors about their financial performance each quarter.

Comparison to Industry Standards

• The timing of the announcement and conference call is consistent with industry practices for quarterly earnings releases.
• Many biopharmaceutical companies follow a similar pattern of releasing results after market close and hosting a conference call shortly after.

Stakeholder Impact

• Shareholders will receive information about the company's financial performance.
• Investors will have the opportunity to ask questions during the conference call.
• The announcement provides transparency to the market.

Next Steps

• Supernus Pharmaceuticals will release its first quarter 2024 financial results on May 8, 2024.
• The company will host a conference call and webcast on May 8, 2024, at 4:30 p.m. ET.

Key Dates

Keywords

Supernus Pharmaceuticals, Financial Results, First Quarter 2024, Conference Call, Webcast, CNS, Biopharmaceutical